Swedish Orphan Biovitrum AB (STO: SOBI)

https://www.sobi.com

Sobi is an international specialty healthcare company dedicated to rare diseases. Sobi’s mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Haemophilia, Inflammation and Genetic diseases. Sobi also markets a portfolio of specialty and rare disease products across Europe, the Middle East, North Africa and Russia for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2016 Sobi had total revenues of SEK 5.2 billion (USD 608 M) and about 760 employees. The share (STO: SOBI) is listed on Nasdaq Stockholm. *

	Start	2010-01-14 renamed date ca
	Group	Swedish Orphan Biovitrum (Sobi) (Group)
	Predecessor	Biovitrum AB
	Industry	DRUGS, ORPHAN
	Person	Oelkers, Guido (Swedish Orphan Biovitrum 201705– CEo before BSN Medical GmbH + Nycomed)
	Person 2	Wallin, Mats-Olof (Swedish Orphan Biovitrum 201710 CFO before Biotage/Pyrosequencing 200302–201112 CFO LEFT 12/11)

	Region	Solna
	Country	Sweden
	Street	23A Tomtebodavägen
	City	17165 Solna
	Tel	+46-8-697-2000
		Address record changed: 2020-12-02

Basic data	Employees	F: 1,001 to 5,000 (2024-12-31)
	Currency	SEK
	Annual sales	26,027,000,000 (revenues, total, consolidated (2024) 2024-12-31)
	Profit	3,879,000,000 (2024-12-31)
	Cash	1,140,000,000 (2024-12-31)

		* Document for »About Section«:

		Record changed: 2026-05-02

Picture Berlin Partner Portrait Bio:cap Investival for You 650x200px

More documents for Swedish Orphan Biovitrum (Sobi) (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)